Potent and selective next generation inhibitor of nicotinamide phosphoribosyl transferase (NAMPT), inhibiting NAD+ biosynthesis from nicotinamide. It reduces the viability of most B-ALL cells with high potency (low nM range), eliminates leukemia stem cells from mouse bone marrow and induces...
Know who made it. See the evidence. Buy through one marketplace.
Potent and selective next generation inhibitor of nicotinamide phosphoribosyl transferase (NAMPT), inhibiting NAD+ biosynthesis from nicotinamide. It reduces the viability of most B-ALL cells with high potency (low nM range), eliminates leukemia stem cells from mouse bone marrow and induces regression of ALL xenografts. It induces apoptosis and reduced neuroblastoma stem cell neurosphere formation in high-risk neuroblastoma cell lines. STF-118804 reduces the growth of pancreatic ductal adenocarcinoma cells
This product is manufactured by TriBio Science and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
NAMPT identifies nicotinamide phosphoribosyltransferase in Homo sapiens (Human). This target record connects NCBI Gene 10135, UniProtKB P43490 and related ABMIUM catalogue products.
